Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.05 USD | -1.60% | +4.39% | -2.75% |
09/05 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
09/05 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.75% | 222M | |
+7.52% | 115B | |
+12.61% | 107B | |
-13.44% | 22.31B | |
-3.99% | 21.6B | |
-6.38% | 18.23B | |
-39.93% | 17.62B | |
+6.87% | 14.26B | |
+32.73% | 12.37B | |
-28.14% | 8.28B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- INmune Bio Alzheimer's Treatment Remains on Clinical Hold After FDA Requests Information; Shares Slump After Hours